TY - JOUR
T1 - Laboratory markers and the risk of developing HIV-1 disease among injecting drug users
AU - Alcabes, Philip
AU - Selwyn, Peter A.
AU - Davenny, Katherine
AU - Hartel, Diana
AU - Buono, Donna
AU - Schoenbaum, Ellie E.
AU - Klein, Robert S.
AU - Friedland, Gerald H.
N1 - Copyright:
Copyright 2020 Elsevier B.V., All rights reserved.
PY - 1994/1
Y1 - 1994/1
N2 - Objective: To characterize the progression to HIV-1 disease among injecting drug users (IDU) according to laboratory markers. Design: Prospective study of cohort of HIV-1-seroprevalent IDU, with case-comparison component. Methods: Different laboratory markers were examined as predictors of progression to HIV-1-associated diseases including AIDS in a cohort of 318 HIV-1-infected IDU. The cohort was enrolled from a methadone treatment program in the Bronx, New York, USA. The independent utility of non-CD4 cell markers was evaluated after adjustment for the association of low CD4 lymphocyte count with AIDS risk. Clinical events in the natural history of HIV-1 were related to changes in levels of two variables related to duration of infection, CD4 lymphocyte count and serum β2-microglobulin (β2M) concentration. Results: On univariate analysis, AIDS incidence measured from baseline increased with declining CD4 lymphocyte number and percentage, increasing serum β2M level, low platelet count, low leukocyte count and p24 antigenemia. Among HIV-1-related outcomes prior to any AIDS diagnosis, the relative risk of pyogenic bacterial infections conferred by these markers was similar to the relative risk of AIDS. For all HIV-1 outcomes, the elevated risk encountered at CD4 lymphocyte number ≤ 200 x 106/l was entirely due to the high risk at ≤ 150 x 106/l. On multivariate analysis, control for CD4 lymphocyte count eliminated the association of any other marker with increased AIDS hazard. HIV-1-related outcomes tended to occur in this order: multiple constitutional symptoms, oral candidiasis, pyogenic bacterial infections and AIDS. Conclusions: In HIV-1-infected IDU, several laboratory markers may predict AIDS when analyzed individually. These are not, however, independently related to increased AIDS risk after adjustment for low CD4 lymphocyte count. A CD4 count ≤ 150 x 106/l is more strongly related to immediate risk of adverse outcome than a count of 200 x 106/l. A progressive series of clinical events is associated with markers of duration of HIV-1 infection, prior to and including AIDS diagnosis.
AB - Objective: To characterize the progression to HIV-1 disease among injecting drug users (IDU) according to laboratory markers. Design: Prospective study of cohort of HIV-1-seroprevalent IDU, with case-comparison component. Methods: Different laboratory markers were examined as predictors of progression to HIV-1-associated diseases including AIDS in a cohort of 318 HIV-1-infected IDU. The cohort was enrolled from a methadone treatment program in the Bronx, New York, USA. The independent utility of non-CD4 cell markers was evaluated after adjustment for the association of low CD4 lymphocyte count with AIDS risk. Clinical events in the natural history of HIV-1 were related to changes in levels of two variables related to duration of infection, CD4 lymphocyte count and serum β2-microglobulin (β2M) concentration. Results: On univariate analysis, AIDS incidence measured from baseline increased with declining CD4 lymphocyte number and percentage, increasing serum β2M level, low platelet count, low leukocyte count and p24 antigenemia. Among HIV-1-related outcomes prior to any AIDS diagnosis, the relative risk of pyogenic bacterial infections conferred by these markers was similar to the relative risk of AIDS. For all HIV-1 outcomes, the elevated risk encountered at CD4 lymphocyte number ≤ 200 x 106/l was entirely due to the high risk at ≤ 150 x 106/l. On multivariate analysis, control for CD4 lymphocyte count eliminated the association of any other marker with increased AIDS hazard. HIV-1-related outcomes tended to occur in this order: multiple constitutional symptoms, oral candidiasis, pyogenic bacterial infections and AIDS. Conclusions: In HIV-1-infected IDU, several laboratory markers may predict AIDS when analyzed individually. These are not, however, independently related to increased AIDS risk after adjustment for low CD4 lymphocyte count. A CD4 count ≤ 150 x 106/l is more strongly related to immediate risk of adverse outcome than a count of 200 x 106/l. A progressive series of clinical events is associated with markers of duration of HIV-1 infection, prior to and including AIDS diagnosis.
KW - AIDS
KW - CD4 lymphocytes
KW - HIV
KW - β-microglobulin
UR - http://www.scopus.com/inward/record.url?scp=0028268153&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0028268153&partnerID=8YFLogxK
U2 - 10.1097/00002030-199401000-00016
DO - 10.1097/00002030-199401000-00016
M3 - Article
C2 - 7912083
AN - SCOPUS:0028268153
SN - 0269-9370
VL - 8
SP - 107
EP - 115
JO - AIDS
JF - AIDS
IS - 1
ER -